Date: October 06, 2026

Board Meeting Outcomes

  • The National Stock Exchange of India Limited (NSE) granted in-principle approval for a preferential issue via letter reference no. NSE/LIST/57059 dated October 06, 2026.
  • BSE Limited granted in-principle approval for the same issue via letter reference no. LOD/PREF/RB/FIP/885/2026-27 dated October 06, 2026.
  • The approval is for the issue and allotment of 4,78,435 equity shares of ₹10 each at an issue price of ₹1,994 per equity share to a non-promoter entity on a preferential basis.
  • The approval is granted under Regulation 28(1) of the SEBI Listing Regulations.

Conditions and Compliance Requirements

  • The company must file the listing application at the earliest from the date of allotment.
  • The company must receive statutory and other approvals and comply with guidelines/regulations issued by SEBI, RBI, MCA, etc.
  • The company must comply with all applicable guidelines, regulations, and directions of the Exchange or any statutory authorities as on the date of the listing application.
  • The company must comply with all conditions as per the SEBI (LODR) Regulations, 2015, Companies Act, 1956/2013, and other applicable laws.
  • The company must submit documents as required by NSE and pay applicable fees.
  • The company is advised to strengthen internal controls to monitor trades executed by the proposed allottees in the company's scrip before allotment.
  • The company must obtain an undertaking from the allottee(s) confirming they will not engage in intra-day trading or any sale in the company's scrip until the allotment date.
  • The responsibility is solely on the issuer company to verify the undertaking and ensure compliance with applicable provisions, including Regulation 167(6) of SEBI ICDR Regulations, 2018.
  • Any non-compliances observed by the exchanges post-undertaking and verification may impact the listing of such shares.
  • The company must make an application for listing within twenty days from the date of allotment as per SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023.

Additional Notes

  • The in-principle approval does not constitute approval under any other Act/Regulation/rule/by-laws, and the company must seek separate approvals from concerned departments if required.
  • The exchanges reserve the right to withdraw the in-principle approval if submitted information is found incomplete/incorrect/misleading/false or in contravention of any rules, regulations, or guidelines.
  • The disclosure is made under Regulation 30 of the SEBI Listing Regulations and will be hosted on the company's website www.tegaindustries.com.